Christine Roth, Bayer global oncology head

'Pluck­ing our way up that list': Bay­er high­lights on­col­o­gy am­bi­tions in new Kendall Square labs

It’s been just a few months since Bay­er opened its new $140 mil­lion on­col­o­gy re­search and in­no­va­tion cen­ter in Cam­bridge, MA, just down the road from its old Kendall Square digs. Now it’s all hands on deck to beef up the pipeline — and that means deals are com­ing, ac­cord­ing to glob­al on­col­o­gy head Chris­tine Roth.

Though the phar­ma gi­ant is still hold­ing its cards close to the vest, Roth told End­points News on Wednes­day that she’s most in­ter­est­ed right now “in that Phase I-plus space.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.